Selumetinib gets the U.S. Breakthrough Therapy Designation Selumetinib- an investigational drug, for the treatment of pediatric patients aged three years and above suffering from symptomatic and/or...
Autism developmental disorder (ASD) is a life-long condition that affects how a person communicates socially. It usually begins early in life and the folks suffering from it face problems while interacting with other people around. This condition brings a range of symptoms with itself like unable to make eye-contac...
Find MoreMultiple Myeloma Day Multiple Myeloma is relatively a rare disease. It accounts for approximately 1% of all cancers and 10% of all blood and bone marrow cancers. For more information on Multiple Myeloma, click here-https://bit.ly/2HKs5da
Find MoreColdZyme inactivates 99% of viruses causing common cold An Oral spray ColdZyme contains a solution of proteolytic enzyme trypsin and glycerol, which happens to shorten the duration of the common cold and also reduces its gravity. A recent research by Enzymatica-a Swedish based life sciences company shows the cli...
Find MoreRare diseases are mostly serious, chronic and life-threatening, associated with both psychological as well as financial burdens. In addition, only a few of them have effective drug treatment available. The European Union (EU) definition of a rare disease is one that affects fewer than 5 in 10,000 people. These affe...
Find MoreA rare disease is any disease that affects a small percentage of the population. In some parts of the world, an orphan disease is a rare disease whose rarity means there is a lack of a market large enough to gain support and resources for discovering treatments for it, except by the government g...
Find MoreCRISPR treatment delivers benefits in mice The researchers from Duke University along with drugmaker Sarepta Therapeutics published a report stating that a single change in the genetic system of Duchenne muscular dystrophy (DMD) affected mice, using CRISPR gene editing tool resulted in increasing their life spa...
Find MoreNeurogene raises USD 68.5 Million for rare neurological diseases Neurogene netted USD 68.5 million to advance multiple gene therapy programs in its series A round. The idea is to take its major programs into IND-enabling studies for Aspartylglucosaminuria (AGU) and a rare form of Charcot-Marie Tooth disease with...
Find Morehttps://www.slideshare.net/DelveInsight/myasthenia-gravis-126250701?qid=b9adbccf-6d91-4e5e-84e1-7603c87a029e&v=&b=&from_search=1 Myasthenia gravis (MG) is an autoimmune syndrome caused by the failure of neuromuscular transmission, which results from the binding of autoantibodies to proteins involved i...
Find Morehttps://www.slideshare.net/DrBKAgrawal/neuroendocrine-tumors-nets?qid=c34d63bb-8495-4c65-9f4e-9348d299ed70&v=&b=&from_search=1 Neuroendocrine tumors (NETs) consists of a complex group of tumors that arise from cells called neuroendocrine cells. For more, view the presentation. For sample repor...
Find MoreHalitosis is an oral health problem caused by volatile molecules which are formed because of patholo.....
Find MoreToll-like receptors (TLR) 7 and 8 are functionally localized to endosomes and recognize specific RNA.....
Find MoreT cell Lymphoma (TCL) is cancer that develops in the T-lymphocytes. T-cell Lymphomas are majorly cla.....
Find MoreOver the last months, the world has faced one of the most unexpected challenges in the form of a nov.....
Find MoreMedical device manufacturing and development is a high-capital demanding endeavor and therefore the .....
Find MoreRheumatoid Arthritis (RA) is a chronic, inflammatory autoimmune disease that leads to progressive an.....
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.